Skip to Main Content

Paper Details

FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.
Eur J Hum Genet
2
2023
ER, ER-, ER-negative, ER-negative breast cancer, FANCM, FANCM missense variants, MVs, TNBC, TNBC subtypes, breast cancer, functional domains, germline, missense variants, moderate-, women
Author NameAffiliation
Sabine BehrensGerman Cancer Research Center (DKFZ)
Javier Ben??tezSpanish National Cancer Research Centre (CNIO)
Javier Ben??tezInstituto de Salud Carlos III
Melissa H Cessna
Stephen J ChanockNational Cancer Institute, National Institutes of Health
Stephen J ChanockNational Cancer Institute, National Institutes of Health
Peter A FaschingUniversity Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg
Jonine D FigueroaNational Cancer Institute, National Institutes of Health
Jonine D FigueroaThe University of Edinburgh
Jonine D FigueroaThe University of Edinburgh
Jonine D FigueroaNational Cancer Institute, National Institutes of Health
Jonine D FigueroaThe University of Edinburgh
Jonine D FigueroaThe University of Edinburgh
Montserrat Garcia-ClosasNational Cancer Institute, National Institutes of Health
Montserrat Garcia-ClosasNational Cancer Institute, National Institutes of Health
Felix GrassmannKarolinska Institutet
Felix GrassmannHealth and Medical University
Per HallKarolinska Institutet
Per Hall
Vessela N KristensenOslo University Hospital and University of Oslo
Jolanta LissowskaM. Sklodowska-Curie National Research Oncology Institute
Jolanta LissowskaM. Sklodowska-Curie National Research Oncology Institute
Jan LubinskiPomeranian Medical University, International Hereditary Cancer Center
Jan LubinskiPomeranian Medical University, International Hereditary Cancer Center
Siranoush ManoukianFondazione IRCCS Istituto Nazionale dei Tumori di Milano
Valerie RheniusUniversity of Cambridge
Xiaohong R YangNational Cancer Institute, National Institutes of Health
Xiaohong R YangNational Cancer Institute, National Institutes of Health
Alison M DunningUniversity of Cambridge
Douglas F EastonUniversity of Cambridge
Douglas F EastonUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Irene L AndrulisLunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics
Irene L AndrulisUniversity of Toronto
Irene L AndrulisLunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics
Irene L AndrulisUniversity of Toronto
Jenny Chang-ClaudeGerman Cancer Research Center (DKFZ)
Jenny Chang-ClaudeUniversity Medical Center Hamburg-Eppendorf, University Cancer Center Hamburg (UCCH)
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Roger L MilneMonash University, School of Clinical Sciences at Monash Health
Roger L MilneThe University of Melbourne
Roger L Milne
Paolo RadiceFondazione IRCCS Istituto Nazionale dei Tumori (INT)
  • 1 - 47

Datasets